KI
SAGE

Kula Investments’s Sage Therapeutics SAGE Stock Holding History

Kula Investments’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$347K Buy
+8,273
New +$356K 0.09% 416

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Kula Investments's SAGE Position: Q1 2023 in Review

Kula Investments opened a new position in Sage Therapeutics (SAGE) in Q1 2023: 8,273 shares worth $347K. The stake represents 0.09% of the portfolio and ranks #416 among its holdings.

212 funds tracked by Wall St. Rank hold SAGE as of Q1 2023.

  • Kula Investments held 8,273 shares of Sage Therapeutics worth $347K as of Q1 2023.
  • Sage Therapeutics was a new Kula Investments position in Q1 2023.
  • Sage Therapeutics made up 0.09% of Kula Investments's portfolio in Q1 2023, its #416 holding.
  • 212 funds tracked by Wall St. Rank held Sage Therapeutics as of Q1 2023.

Based on Kula Investments's 13F filing for Q1 2023, filed 15 May 2023.